Evidence map›Paper›PMID 31385275›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

Genetic Manipulation of Chlamydia trachomatis: Chromosomal Deletions.

Katerina Wolf, Mostafa Rahnama, Kenneth A Fields

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Editorial:Frontiers in cellular and infection microbiology · 2024
    Article
  6. Frontiers in cellular and infection microbiology · 2023
    Article
  7. Advances in genetic manipulation ofFrontiers in immunology · 2023
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katerina WolfDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, USA.
Mostafa RahnamaDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, USA.
Kenneth A FieldsDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY, USA. Ken.fields@uky.edu.

Funding

Type III exported effectors of Chlamydia trachomatisR01AI065530 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FIELDS, KENNETH A · 2005 to 2021
$5.7M
Mutagenesis in Chlamydia trachomatis via allelic exchangeR21AI124649 · NIAID · UNIVERSITY OF KENTUCKY · PI FIELDS, KENNETH A · 2016 to 2017
$409k
Conditional Null Mutants in the Study Essential Gene Products of ChlamydiaR21AI144648 · NIAID · UNIVERSITY OF KENTUCKY · PI FIELDS, KENNETH A · 2019 to 2020
$406k
NIAID NIH HHS R01 AI065530NIAID NIH HHS R21 AI124649NIAID NIH HHS R21 AI144648
6 · The paper itself

Abstract

Progress in understanding molecular mechanisms contributing to chlamydial pathogenesis has been greatly facilitated by recent advances in genetic manipulation of C. trachomatis. Valuable approaches such as random, chemically induced mutagenesis or targeted, insertion-based gene disruption have led to significant discoveries. We describe herein a technique for generating definitive null strains via complete deletion of chromosomal genes in C. trachomatis. Fluorescence-reported allelic exchange mutagenesis (FRAEM), using the suicide vector pSUmC, enables targeted deletion of desired chromosomal DNA. The protocol provided here describes steps required to produce transformation competent chlamydiae, generate a specific allelic exchange plasmid construct, carry out mutagenesis, and isolate clonal populations of resulting mutant strains.

Indexed as

Gene DeletionMutagenesisAllelesChlamydia InfectionsChlamydia trachomatisChromosomes, BacterialGene TargetingHumansTransformation, GeneticAllelic exchangeFRAEMMutagenesis

Identifiers

PMID31385275
PMCPMC7568443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.